Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2023 08:00 ET | Source: VantAI

VantAI Announces Formation of Scientific Advisory Board

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- VantAI, a leading company focused on the application of artificial intelligence to drug discovery, today announced its newly formed Scientific Advisory...
July 27, 2023 08:00 ET | Source: VantAI

Geometric Deep Learning Pioneer Michael Bronstein joins VantAI as Chief Scientist in Residence to Help Drive Artificial Intelligence Breakthroughs in Drug Discovery

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- VantAI, a leader in ML technologies for drug discovery, is excited to announce the appointment of Dr. Michael Bronstein as Chief Scientist in Residence....
April 20, 2022 07:00 ET | Source: VantAI

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders

VantAI will pair its induced proximity platform with BI’s deep early discovery experience to identify targeted protein degraders with enhanced properties for traditionally “undruggable” targets NEW...
April 13, 2022 07:00 ET | Source: VantAI

VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- VantAI, an AI-first induced-proximity company, today announced it has entered into a multi-year collaboration agreement with Janssen Pharmaceutica NV,...